Brighton Jones’s Recursion Pharmaceuticals RXRX Stock Holding History
Bought
Maintained
Sold
Other funds holding RXRX
Brighton Jones's RXRX Position: Q3 2026 in Review
Brighton Jones increased its Recursion Pharmaceuticals (RXRX) stake by 2.3% in Q3 2026, buying an estimated $2.05K and bringing the position to 27,337 shares worth $113K. The position accounts for ﹤0.01% of the portfolio, ranked #1313.
Brighton Jones first reported a position in RXRX in Q3 2024 and has held it in 8 quarters since. The position peaked at $148K in Q2 2025. 291 funds tracked by Wall St. Rank hold RXRX as of Q3 2026.
- Brighton Jones held 27,337 shares of Recursion Pharmaceuticals worth $113K as of Q3 2026.
- Brighton Jones bought 604 Recursion Pharmaceuticals shares in Q3 2026, an estimated $2.05K.
- Recursion Pharmaceuticals made up ﹤0.01% of Brighton Jones's portfolio in Q3 2026, its #1313 holding.
- Brighton Jones first reported a position in Recursion Pharmaceuticals in Q3 2024 and has held it in 8 quarters since.
- Brighton Jones's Recursion Pharmaceuticals position peaked at $148K in Q2 2025.
- 291 funds tracked by Wall St. Rank held Recursion Pharmaceuticals as of Q3 2026.
Based on Brighton Jones's 13F filing for Q3 2026, filed 3 Nov 2026.